Scientists have identified a protein that acts like a brake on the nervous system's ability to repair damaged connections, a discovery that could eventually lead to new treatments for nerve and spinal cord injuries. The research shows that blocking this protein, known as AHR, helped injured nerve fibers regrow and improved movement and sensation in mice.
The findings address a long-standing question in neuroscience: why damaged nerves struggle to heal. When neurons are injured, they often enter a state focused on survival rather than active rebuilding. The newly identified mechanism suggests that AHR plays a central role in keeping neurons in that survival mode, preventing them from launching a full regenerative response.
In experiments described by the research team, mice with nerve or spinal cord injuries showed measurable improvements after AHR was blocked. Injured nerve fibers regrew more effectively, and the animals regained better motor function and sensory responses compared with untreated controls. The results point toward a possible strategy for shifting neurons from simply surviving an injury to actively rebuilding their connections.
The work is still at an early stage, and the experiments were conducted in animal models rather than human patients. However, the identification of AHR as a regulatory target opens a concrete avenue for drug development. Future therapies might aim to temporarily suppress AHR activity after injury, creating a window in which the nervous system is more receptive to repair.
Nerve damage from trauma, surgery, or disease currently has very limited treatment options. Peripheral nerve injuries can cause lasting loss of movement and sensation, while spinal cord injuries often result in permanent disability. A therapy that could enhance the body's own repair mechanisms would address a major unmet medical need.
The research adds to a growing understanding of the molecular signals that control nerve regeneration. Scientists have known for years that adult neurons retain some capacity to grow, but that capacity is suppressed. Identifying the specific proteins responsible for that suppression is a critical step toward designing interventions that release the brake.
The team behind the study says the next phase of research will focus on understanding exactly how AHR interacts with other cellular pathways involved in regeneration. They also plan to test whether blocking AHR remains effective in more complex injury models and over longer recovery periods.
If those studies succeed, the approach could eventually be combined with rehabilitation or surgical repair to improve outcomes for patients with nerve injuries. The discovery does not yet offer a cure, but it provides a clear molecular target and a rationale for developing drugs that could make a meaningful difference in recovery.
